These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6073293)

  • 1. [17-oxycorticosteroid content in the fibrinolytic blood plasma].
    Kuleshov IuIa; Murashov BF; Stel'makh VI
    Probl Gematol Pereliv Krovi; 1967 Apr; 12(4):25-7. PubMed ID: 6073293
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of fibrinolysis blood in patients with acute surgical diseases and injuries].
    Chetverushkin BV; Stazhadze LL; Borovkova TF
    Vestn Akad Med Nauk SSSR; 1991; (9):27-30. PubMed ID: 1750238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [11-oxycorticosteroid level in the blood and the cytomorphological characteristics of wounds in patients with thermal burns].
    Shesternia NA; Gladshteĭn AI
    Ortop Travmatol Protez; 1969 Sep; 30(9):21-4. PubMed ID: 5381348
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biomedical aspects of the use of cadaver blood].
    Khvatov VB
    Vestn Akad Med Nauk SSSR; 1991; (9):18-24. PubMed ID: 1750236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ON THE FIBRINOLYTIC ACTIVITY OF PRESERVED CADAVER BLOOD].
    DERVIZ GV; SABUROVA IV; LAZAREVSKII SA
    Probl Gematol Pereliv Krovi; 1964 Mar; 9():49-53. PubMed ID: 14165267
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possibilities in the preservation of human plasma by use of human erythrocyte suspension under clinical conditions].
    Weiss W
    Z Arztl Fortbild (Jena); 1976 Jun; 70(11):579-80. PubMed ID: 952021
    [No Abstract]   [Full Text] [Related]  

  • 7. [Change of the blood coagulation system in burned patients after transfusion of fibrinolytic plasma].
    Denisov VM; Levin GIa
    Ortop Travmatol Protez; 1973 Jul; 34(7):62-4. PubMed ID: 4786346
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of cadaver blood in the treatment of thromboembolic diseases].
    Zykova KI
    Voen Med Zh; 1969 Dec; 12():72-3. PubMed ID: 5367241
    [No Abstract]   [Full Text] [Related]  

  • 9. [Technic for obtaining of fibrinolysed blood].
    Rudykh OD; Marulin BA; Belichenko LI
    Probl Gematol Pereliv Krovi; 1967 Sep; 12(9):51-2. PubMed ID: 5620135
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problems associated with transfusion of post mortem blood].
    Volk P; Gostomzyk JG; Schäfer B; Reck R
    Z Rechtsmed; 1970; 67(1):1-18. PubMed ID: 4924651
    [No Abstract]   [Full Text] [Related]  

  • 11. A study on the fibrinolytic activity of cadaveric blood: isolation and characterization of plasminogen activator from cadaveric plasma after sudden death.
    Nakasono I
    Nihon Hoigaku Zasshi; 1984 Jun; 38(3):280-8. PubMed ID: 6541262
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of continuous-flow automated plateletpheresis on fibrinolytic activity of donor plasma.
    Radziwon P; Boczkowska-Radziwon B; Lipska A; Smoktunowicz M; Kloczko J
    Transfus Med; 2005 Aug; 15(4):319-22. PubMed ID: 16101810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some characteristics of postagonal blood].
    Gutiontova KP
    Probl Gematol Pereliv Krovi; 1968 May; 13(5):20-1. PubMed ID: 5735554
    [No Abstract]   [Full Text] [Related]  

  • 14. Time course of clotting and fibrinolytic markers in acute upper gastrointestinal bleeding: relation to diagnosis and blood transfusion treatment.
    Henriksson AE; Nilsson TK; Svensson JO
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):877-80. PubMed ID: 7511945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physicochemical characteristics of the erythrocytes of fibrinolytic blood].
    Denisov VM; Tiukina AA
    Probl Gematol Pereliv Krovi; 1978 Aug; 23(8):13-6. PubMed ID: 683982
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
    Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ
    Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of recombinant human erythropoietin on hemostasis, fibrinolysis, and blood rheology in autologous blood donors.
    Biesma DH; Bronkhorst PJ; de Groot PG; van de Wiel A; Kraaijenhagen RJ; Marx JJ
    J Lab Clin Med; 1994 Jul; 124(1):42-7. PubMed ID: 8035101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TREATMENT OF PATIENTS WITH INFECTIOUS HEPATITIS WITH FIBRINOLYTIC AND PRESERVED BLOOD PLASMA].
    ALISOV PA; STARSHOV PD; KOVALSKII Ia
    Voen Med Zh; 1964; 11():17-20. PubMed ID: 14278528
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrinolytic activity in blood is distributed over a cellular and the plasma fraction which can be modulated separately.
    van Giezen JJ; Chung-A-Hing JE; Vegter CB; Bouma BN; Jansen JW
    Thromb Haemost; 1994 Dec; 72(6):887-92. PubMed ID: 7740459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemorheological, coagulative and fibrinolytic changes during autologous blood donation.
    Clivillé X; Bofill C; Joven J; Monasterio J; Viscor G; Vernis M; Angles A; Sans T
    Clin Hemorheol Microcirc; 1998 Jul; 18(4):265-72. PubMed ID: 9741667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.